Two Sigma Advisers’s Dynavax Technologies DVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-1,318,218
| Closed | -$20.3M | – | 636 |
|
|
2025
Q4 | $20.3M | Sell |
1,318,218
-263,900
| -17% | -$2.91M | 0.04% | 351 |
|
|
2025
Q3 | $15.7M | Sell |
1,582,118
-358,500
| -18% | -$3.73M | 0.03% | 377 |
|
|
2025
Q2 | $19.3M | Buy |
1,940,618
+1,019,800
| +111% | +$10.7M | 0.04% | 343 |
|
|
2025
Q1 | $11.9M | Buy |
920,818
+786,300
| +585% | +$10.4M | 0.03% | 479 |
|
|
2024
Q4 | $1.72M | Sell |
134,518
-30,600
| -19% | -$370K | ﹤0.01% | 1187 |
|
|
2024
Q3 | $1.84M | Buy |
165,118
+114,300
| +225% | +$1.26M | ﹤0.01% | 1117 |
|
|
2024
Q2 | $571K | Buy |
50,818
+34,800
| +217% | +$405K | ﹤0.01% | 1827 |
|
|
2024
Q1 | $199K | Sell |
16,018
-144,900
| -90% | -$1.89M | ﹤0.01% | 2215 |
|
|
2023
Q4 | $2.25M | Sell |
160,918
-462,170
| -74% | -$6.42M | 0.01% | 1222 |
|
|
2023
Q3 | $9.2M | Sell |
623,088
-363,400
| -37% | -$5.11M | 0.02% | 494 |
|
|
2023
Q2 | $12.7M | Sell |
986,488
-49,300
| -5% | -$562K | 0.03% | 423 |
|
|
2023
Q1 | $10.2M | Sell |
1,035,788
-57,800
| -5% | -$617K | 0.03% | 547 |
|
|
2022
Q4 | $11.6M | Sell |
1,093,588
-201,900
| -16% | -$2.35M | 0.03% | 471 |
|
|
2022
Q3 | $13.5M | Sell |
1,295,488
-386,800
| -23% | -$5.04M | 0.04% | 419 |
|
|
2022
Q2 | $21.2M | Sell |
1,682,288
-38,400
| -2% | -$408K | 0.06% | 312 |
|
|
2022
Q1 | $18.7M | Buy |
1,720,688
+9,700
| +0.6% | +$118K | 0.05% | 339 |
|
|
2021
Q4 | $24.1M | Sell |
1,710,988
-323,200
| -16% | -$5.32M | 0.06% | 271 |
|
|
2021
Q3 | $39.1M | Buy |
2,034,188
+1,524,000
| +299% | +$20.2M | 0.1% | 199 |
|
|
2021
Q2 | $5.03M | Buy |
510,188
+495,100
| +3,281% | +$4.5M | 0.01% | 868 |
|
|
2021
Q1 | $148K | Sell |
15,088
-353,370
| -96% | -$2.91M | ﹤0.01% | 2395 |
|
|
2020
Q4 | $1.64M | Sell |
368,458
-441,400
| -55% | -$2M | ﹤0.01% | 1359 |
|
|
2020
Q3 | $3.5M | Buy |
+809,858
| New | +$5.78M | 0.01% | 891 |
|
|
2018
Q3 | – | Sell |
-12,382
| Closed | -$189K | – | 2270 |
|
|
2018
Q2 | $189K | Buy |
+12,382
| New | +$214K | ﹤0.01% | 2208 |
|
|
2017
Q4 | – | Sell |
-10,982
| Closed | -$236K | – | 2267 |
|
|
2017
Q3 | $236K | Buy |
+10,982
| New | +$174K | ﹤0.01% | 2001 |
|
|
2016
Q2 | – | Sell |
-25,100
| Closed | -$483K | – | 2077 |
|
|
2016
Q1 | $483K | Buy |
+25,100
| New | +$507K | ﹤0.01% | 1474 |
|
Other funds holding DVAX
Two Sigma Advisers's DVAX Position: Q1 2026 in Review
Two Sigma Advisers sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 1,318,218 shares — an estimated $20.3M sold.
Two Sigma Advisers first reported a position in DVAX in Q1 2016 and held it in 25 quarters. The position peaked at $39.1M in Q3 2021. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.
- Two Sigma Advisers reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
- Two Sigma Advisers sold 1,318,218 Dynavax Technologies shares in Q1 2026, an estimated $20.3M.
- Two Sigma Advisers first reported a position in Dynavax Technologies in Q1 2016 and held it in 25 quarters.
- Two Sigma Advisers's Dynavax Technologies position peaked at $39.1M in Q3 2021.
- 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.
Based on Two Sigma Advisers's 13F filing for Q1 2026.